HJV
Hemojuvelin
Also known as: haemojuvelin, hemojuvelin, HFE2, HFE2A, JH, RGMC, RGMC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZVN8
- Gene
- HJV
- Ensembl
- ENSG00000168509
- Chromosome
- 1
- Canonical length
- 426 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
The product of this gene is involved in iron metabolism. It may be a component of the signaling pathway which activates hepcidin or it may act as a modulator of hepcidin expression. It could also represent the cellular receptor for hepcidin. Two uORFs in the 5' UTR negatively regulate the expression and activity of the encoded protein. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. Defects in this gene are the cause of hemochromatosis type 2A, also called juvenile hemochromatosis (JH). JH is an early-onset autosomal recessive disorder due to severe iron overload resulting in hypogonadotrophic hypogonadism, hepatic fibrosis or cirrhosis and cardiomyopathy, occurring typically before age of 30. [provided by RefSeq, Oct 2015]
Canonical amino-acid sequenceUniProt
426 residues, UniProt reviewed canonical sequence.
>Q6ZVN8|HJV
1 MGEPGQSPSP RSSHGSPPTL STLTLLLLLC GHAHSQCKIL RCNAEYVSST LSLRGGGSSG
61 ALRGGGGGGR GGGVGSGGLC RALRSYALCT RRTARTCRGD LAFHSAVHGI EDLMIQHNCS
121 RQGPTAPPPP RGPALPGAGS GLPAPDPCDY EGRFSRLHGR PPGFLHCASF GDPHVRSFHH
181 HFHTCRVQGA WPLLDNDFLF VQATSSPMAL GANATATRKL TIIFKNMQEC IDQKVYQAEV
241 DNLPVAFEDG SINGGDRPGG SSLSIQTANP GNHVEIQAAY IGTTIIIRQT AGQLSFSIKV
301 AEDVAMAFSA EQDLQLCVGG CPPSQRLSRS ERNRRGAITI DTARRLCKEG LPVEDAYFHS
361 CVFDVLISGD PNFTVAAQAA LEDARAFLPD LEKLHLFPSD AGVPLSSATL LAPLLSGLFV
421 LWLCIQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HJV can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 554 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 554 nTPM
- tongue: 272 nTPM
- liver: 224 nTPM
- heart muscle: 63 nTPM
- esophagus: 7.4 nTPM
- salivary gland: 5.5 nTPM
Single-cell type
- hepatocytes: 192 nCPM
- thymic myoid cells: 33 nCPM
- myonuclei: 23 nCPM
- retinal ganglion cells: 19 nCPM
- cardiomyocytes: 11 nCPM
- schwann cells: 11 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 1.6 nTPM
- spinal cord: 1.1 nTPM
- medulla oblongata: 0.9 nTPM
- basal ganglia: 0.7 nTPM
- cerebral cortex: 0.7 nTPM
- midbrain: 0.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HJV.
Disease | AllUniProt
Conditions HJV is implicated in, by any mechanism.
- Hemochromatosis 2A (HFE2A) MIM:602390
Disease | GeneticClinVar
78 pathogenic / likely-pathogenic of 469 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hemochromatosis type 2A
- Hemochromatosis type 1
- Juvenile hemochromatosis
- HJV-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.41
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activin receptor signaling pathway
- BMP signaling pathway
- cellular response to BMP stimulus
- intracellular iron ion homeostasis
- multicellular organismal-level iron ion homeostasis
- negative regulation of BMP signaling pathway
- negative regulation of transcription by RNA polymerase II
- positive regulation of transcription by RNA polymerase II
- protein autoprocessing
- transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HJV in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HJV as an antibody target. Whether an autoantibody or antibody against HJV could matter depends on whether native HJV is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HJV is annotated at the cell surface, where native HJV is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HJV as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...